Summit Trail Advisors, LLC Immuno Gen, Inc. Transaction History

Summit Trail Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $108,661 - $142,270	-12,635 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$9.52 - $12.15 $230,279 - $293,896	-24,189 Reduced 65.69%	12,635 $123,000
Q1 2018 May 22, 2018	SELL	$6.7 - $12.95 $1.36 Million - $2.64 Million	-203,558 Reduced 84.68%	36,824 $240,000
Q1 2018 May 21, 2018	BUY	$6.7 - $12.95 $1.39 Million - $2.69 Million	207,813 Added 638.07%	240,382 $240,000
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $165,124 - $257,946	32,569	32,569 $256,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.